| 1 |
33485079 | Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial. | 2021 Mar |
1 |
| 2 |
33691171 | A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets. | 2021 May 15 |
1 |
| 3 |
33720069 | Changes in the therapeutic landscape of oesophago-gastric cancers. | 2021 Jul 1 |
1 |
| 4 |
31768696 | Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B. | 2020 Jan |
1 |
| 5 |
31851321 | HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial. | 2020 Sep 1 |
1 |
| 6 |
30927036 | Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial. | 2019 Jun |
2 |
| 7 |
31102009 | Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer. | 2019 Nov |
1 |
| 8 |
32157048 | [A Case in Which Trastuzumab Combined Chemotherapy Was Effective for Recurrence of Post-Operative Gastric Cancer with Partial HER2 Overexpression]. | 2019 Dec |
2 |
| 9 |
29310611 | Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy. | 2018 Jan 8 |
2 |
| 10 |
29684854 | The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells. | 2018 Jul |
6 |
| 11 |
29731915 | Target-specific delivery of oxaliplatin to HER2-positive gastric cancer cells in vivo using oxaliplatin-au-fe3o4-herceptin nanoparticles. | 2018 May |
1 |
| 12 |
29978335 | Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. | 2018 Jul 5 |
2 |
| 13 |
30008904 | Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report. | 2018 Aug |
1 |
| 14 |
30587732 | [A Case of Complete Response to Trastuzumab plus S-1 and Oxaliplatin for a HER2-Positive Recurrence of Gastric Cancer]. | 2018 Dec |
1 |
| 15 |
28454407 | Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin. | 2017 Apr |
3 |
| 16 |
28850174 | Chemotherapy for advanced gastric cancer. | 2017 Aug 29 |
1 |
| 17 |
29394602 | [A Case of HER2-Positive Unresectable Gastric Cancer with Multiple Lymph Node and Liver Metastases Controlled Effectively by Combination Chemotherapy with Capecitabine, Oxaliplatin, and Trastuzumab]. | 2017 Nov |
1 |
| 18 |
29394847 | [A Case in Which S-1/Oxaliplatin(SOX)/Trastuzumab Therapy Was Effective for Unresectable HER2 Positive Advanced Gastric Cancer and Radical Resection Could Be Performed]. | 2017 Nov |
1 |
| 19 |
26628478 | Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial. | 2016 Feb 10 |
2 |
| 20 |
26857702 | Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial. | 2016 Feb 8 |
1 |
| 21 |
25624920 | Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins. | 2015 Feb |
2 |
| 22 |
26186063 | Trastuzumab-mediated selective delivery for platinum drug to HER2-positive breast cancer cells. | 2015 Oct |
1 |
| 23 |
24300914 | Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells. | 2014 Mar |
3 |
| 24 |
25232273 | Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy. | 2014 Sep 14 |
1 |
| 25 |
20690802 | A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer. | 2010 Oct |
2 |